Big pharma IS interested at least they are in EKC itself - Alcon has invested $500 million in an EKC aganocide with NovaBay the company involved and they got $100 million from Alcon. And the stuff affects the cornea! Not encouraging for a $500 million investment!
So NNVC is in the right place at the right time particularly when the EKC-Cide we have will NOT affect the cornea. It's time for Alcon to realize this! Or at least some other eye care company. But I guess a $500 million investment is hard to write off as a failure. Like another Edsel.
Market Data 
Markets 
